CLPBY Живые сигналы | Максимизируйте прибыль с Getagraph.com

Live Chart Being Loaded With Signals

Commentary (2 май 2024 @ 21:08):

Coloplast A/S engages in the development and sale of intimate healthcare products and services in Denmark, the United States, the United Kingdom, France, and internationally...

Stats
Объем за сегодня	25 930.00
Средний объем	109 526
Рыночная капитализация	27.05B
EPS	$0.598 ( 2023-06-30 )
Дата следующего отчета о доходах	( $0.0800 ) 2024-05-09
Last Dividend	$0.0740 ( 2023-05-19 )
Next Dividend	$0 ( N/A )
P/E	38.09
ATR14	$0.0500 (0.41%)

Объем Корреляция

Длинно: -0.09 (neutral)

Кратко: 0.12 (neutral)

Signal:(50.111) Neutral

Coloplast A/S Корреляция

10 Самые положительные корреляции

10 Самые отрицательные корреляции

Вы знали?

Корреляция - это статистический показатель, описывающий связь между двумя переменными. Он изменяется от -1 до 1, где -1 указывает на идеальную отрицательную корреляцию (при увеличении одной переменной другая уменьшается), 1 указывает на идеальную положительную корреляцию (при увеличении одной переменной другая увеличивается), а 0 указывает на отсутствие корреляции (между переменными нет связи).

Корреляцию можно использовать для анализа связи между любыми двумя переменными, не только акциями. Она широко используется в таких областях, как финансы, экономика, психология и т. д.

Coloplast A/S Корреляция - Валюта/Сырье

-0.15
( neutral )

-0.11
( neutral )

-0.01
( neutral )

-0.14
( neutral )

-0.75
( moderate negative )

0.15
( neutral )

Coloplast A/S Финансовые показатели

Annual	2023
Выручка:	$24.50B
Валовая прибыль:	$16.33B (66.64 %)
EPS:	$22.21

FY	2023
Выручка:	$24.50B
Валовая прибыль:	$16.33B (66.64 %)
EPS:	$22.21

FY	2022
Выручка:	$22.58B
Валовая прибыль:	$15.53B (68.78 %)
EPS:	$22.15

FY	2021
Выручка:	$19.43B
Валовая прибыль:	$13.31B (68.53 %)
EPS:	$2.27

Financial Reports:

No articles found.

Coloplast A/S Dividends

(Q3/22)	(Q4/22)	(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
$0 (N/A)	$0.210 (N/A)	$0 (N/A)	$0.0740 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)

Coloplast A/S Dividend Information - Ex Dividend Junior

Dividend Sustainability Score: 6.57 - average (85.65%) | Divividend Growth Potential Score: 3.15 - Decrease likely (37.06%)

Very Unsafe

High risk of being cut

Unsafe

Heightened risk of being cut

Borderline

Moderate risk of being cut

Safe

Unlikely to be cut

Very Safe

Very unlikely to be cut

Information

First Dividend	$0.0810	2021-05-14
Last Dividend	$0.0740	2023-05-19
Next Dividend	$0	N/A
Payout Date	2023-05-30
Next Payout Date	N/A
# dividends	5	--
Total Paid Out	$0.649	--
Avg. Dividend % Per Year	0.00%	--
Score	2.51	--
Div. Sustainability Score	6.57
Div.Growth Potential Score	3.15
Div. Directional Score	4.86	--

Next Divdend (Est)
(2024-10-01)

$0.00796 Estimate 3.61 %

Dividend Stability

0.29 Very Poor

Dividend Score

2.51

Pay Frequency

Semi-Annually

Yearly Payout

Year	Amount	Yield

Dividend Commentary

With a moderate Dividend Sustainability Score (DSS), the company may sustain its dividends, but continuous monitoring is advised for any financial shifts. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In conclusion, a more vigilant stance is recommended given the company's tentative dividend landscape.

Top 10 dividend Companies for OTC

Symbol	Title	Last dividend	Frequency	Yearly Dividend
YZCHF	Ex Dividend Junior	2023-07-05	Annually	0.00%
MONDY	Ex Dividend Knight	2023-08-24	Semi-Annually	0.00%
CNLHO	Ex Dividend Knight	2023-07-07	Quarterly	0.00%
STWRY	Ex Dividend Junior	2023-05-19	Annually	0.00%
HKHHY	Ex Dividend Junior	2023-08-10	Annually	0.00%
ANSLY	Ex Dividend Knight	2023-08-23	Semi-Annually	0.00%
OLCLF	Ex Dividend Junior	2023-09-28	Semi-Annually	0.00%
DAIUF	Ex Dividend Knight	2023-09-28	Semi-Annually	0.00%
TROLB	Ex Dividend Knight	2023-06-16	Quarterly	0.00%
IPSEY	Ex Dividend Knight	2023-06-02	Annually	0.00%

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	0.195	1.500	6.11	9.16	[0 - 0.5]
returnOnAssetsTTM	0.100	1.200	6.66	7.99	[0 - 0.3]
returnOnEquityTTM	0.424	1.500	6.40	9.60	[0.1 - 1]
payoutRatioTTM	0.957	-1.000	0.433	-0.433	[0 - 1]
currentRatioTTM	0.532	0.800	-2.34	-1.871	[1 - 3]
quickRatioTTM	0.324	0.800	-2.80	-2.24	[0.8 - 2.5]
cashRatioTTM	0.0484	1.500	-0.842	-1.263	[0.2 - 2]
debtRatioTTM	0.445	-1.500	2.58	-3.87	[0 - 0.6]
interestCoverageTTM	9.31	1.000	7.66	7.66	[3 - 30]
operatingCashFlowPerShareTTM	25.30	2.00	1.568	3.14	[0 - 30]
freeCashFlowPerShareTTM	19.61	2.00	0.195	0.389	[0 - 20]
debtEquityRatioTTM	1.430	-1.500	4.28	-6.42	[0 - 2.5]
grossProfitMarginTTM	0.667	1.000	2.21	2.21	[0.2 - 0.8]
operatingProfitMarginTTM	0.273	1.000	6.53	6.53	[0.1 - 0.6]
cashFlowToDebtRatioTTM	0.256	1.000	9.69	9.69	[0.2 - 2]
assetTurnoverTTM	0.515	0.800	9.90	7.92	[0.5 - 2]
Total Score				6.57

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	3.82	1.000	9.72	0	[1 - 100]
returnOnEquityTTM	0.424	2.50	7.69	9.60	[0.1 - 1.5]
freeCashFlowPerShareTTM	19.61	2.00	3.46	0.389	[0 - 30]
dividendYielPercentageTTM	0.361	1.500	0.971	0	[0 - 0.4]
operatingCashFlowPerShareTTM	25.30	2.00	1.568	3.14	[0 - 30]
payoutRatioTTM	0.957	1.500	0.433	-0.433	[0 - 1]
pegRatioTTM	-0.239	1.500	-4.93	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	0.221	1.000	6.97	0	[0.1 - 0.5]
Total Score				3.15

Coloplast A/S

Coloplast A/S engages in the development and sale of intimate healthcare products and services in Denmark, the United States, the United Kingdom, France, and internationally. The company operates in three segments: Chronic Care, Interventional Urology, and Wound & Skin Care. It provides ostomy care products, including SenSura Mio, which provides fit individual body shapes and optimal discretion for various types of ostomies; and SenSura Ostomy care solutions, as well as ostomy accessories under the Brava brand. The company also offers continence care products, such as Conveen Active urine bags; SpeediCath catheters that offer catheterization for both genders; and Peristeen, a transanal irrigation system. In addition, it provides wound care products comprising conforming dressing under the Biatain Silicone brand and hydrocolloid dressing under the Comfeel brand; and skin care products that include bathing and cleansing products, moisturizers, skin protectants, antifungal products, hand cleanser, and odor control products, as well as InterDry, a skin fold management solution. Further, the company develops, produces, and markets products for the surgical treatment of urological and gynecological disorders, such as urinary stone diseases, benign prostate hyperplasia, voiding dysfunctions, erectile dysfunction, and urinary incontinence. Coloplast A/S was founded in 1954 and is headquartered in Humlebæk, Denmark.